For over 125 years, Roche has been a global leader in healthcare innovation, committed to improving lives by advancing science and providing access to life-saving medicines and diagnostics. Operating in Aotearoa New Zealand through Roche Pharmaceuticals and Roche Diagnostics, the organisation focuses on early detection and treatment of serious illnesses such as cancer, infectious diseases, and cardiovascular conditions. With a strong emphasis on personalised healthcare, Roche tailors solutions to effectively prevent, diagnose, and treat diseases, transforming the lives of thousands of New Zealanders. Roche's commitment to innovation is demonstrated through its significant investment in clinical trials, contributing over $30 million to local research and development in the past five years. This effort has provided access to advanced treatments for over 1000 New Zealanders, underscoring their dedication to delivering sustainable healthcare solutions. With nearly 100 employees in New Zealand and 27 medicines available locally, Roche continues to shape the future of healthcare by ensuring the right medicines reach the right patients at the right time.
Target customer: Roche New Zealand’s primary customers include healthcare providers, hospitals, laboratories, and patients with complex or chronic health conditions who require access to advanced diagnostics and cutting-edge treatments.
Roche
